Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 9 studies | 31% ± 15% | |
intestine | 6 studies | 31% ± 10% | |
pancreas | 5 studies | 51% ± 18% | |
placenta | 4 studies | 46% ± 24% | |
breast | 4 studies | 20% ± 2% | |
liver | 4 studies | 29% ± 11% | |
peripheral blood | 3 studies | 17% ± 2% | |
kidney | 3 studies | 24% ± 6% | |
uterus | 3 studies | 36% ± 16% | |
skin | 3 studies | 16% ± 1% | |
brain | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3247.01 | 180 / 180 | 100% | 184.50 | 430 / 430 |
pancreas | 100% | 12939.46 | 328 / 328 | 100% | 153.43 | 178 / 178 |
stomach | 100% | 2827.70 | 359 / 359 | 100% | 196.32 | 286 / 286 |
liver | 100% | 6131.78 | 225 / 226 | 100% | 185.18 | 406 / 406 |
intestine | 100% | 1962.01 | 965 / 966 | 100% | 221.64 | 525 / 527 |
uterus | 100% | 2790.34 | 170 / 170 | 99% | 192.61 | 456 / 459 |
breast | 100% | 3087.09 | 459 / 459 | 99% | 174.05 | 1108 / 1118 |
skin | 100% | 3853.49 | 1802 / 1809 | 99% | 209.73 | 469 / 472 |
esophagus | 100% | 2108.34 | 1443 / 1445 | 99% | 113.82 | 181 / 183 |
lung | 99% | 2092.94 | 571 / 578 | 100% | 200.88 | 1153 / 1155 |
prostate | 100% | 1878.96 | 244 / 245 | 99% | 224.10 | 496 / 502 |
bladder | 100% | 2081.05 | 21 / 21 | 98% | 189.49 | 495 / 504 |
thymus | 100% | 2253.94 | 652 / 653 | 98% | 98.80 | 595 / 605 |
kidney | 100% | 1653.03 | 89 / 89 | 96% | 139.28 | 862 / 901 |
adrenal gland | 100% | 3494.17 | 257 / 258 | 95% | 154.70 | 218 / 230 |
brain | 78% | 744.53 | 2059 / 2642 | 98% | 125.91 | 690 / 705 |
adipose | 100% | 3275.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 109.83 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 148.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 70.82 | 1 / 1 |
blood vessel | 100% | 3016.69 | 1330 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2910.86 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 2423.74 | 831 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 1036.19 | 746 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 94.42 | 72 / 80 |
peripheral blood | 46% | 947.68 | 430 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0007283 | Biological process | spermatogenesis |
GO_0033554 | Biological process | cellular response to stress |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0022417 | Biological process | protein maturation by protein folding |
GO_0042744 | Biological process | hydrogen peroxide catabolic process |
GO_0030198 | Biological process | extracellular matrix organization |
GO_2000255 | Biological process | negative regulation of male germ cell proliferation |
GO_0007252 | Biological process | I-kappaB phosphorylation |
GO_0008584 | Biological process | male gonad development |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0008379 | Molecular function | thioredoxin peroxidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0140313 | Molecular function | molecular sequestering activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRDX4 |
Protein name | Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4) thioredoxin-dependent peroxiredoxin (EC 1.11.1.24) Peroxiredoxin 4 |
Synonyms | hCG_17636 HEL-S-97n |
Description | FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Regulates the activation of NF-kappa-B in the cytosol by a modulation of I-kappa-B-alpha phosphorylation. . |
Accessions | ENST00000439422.1 A6NG45 H7C3T4 A6NJJ0 ENST00000379341.9 Q13162 ENST00000379349.5 V9HW63 ENST00000379331.3 |